James, V.M., Gill, J.L., Topf, M. and Harvey, R.J. (2012) Molecular mechanisms of glycine transporter GlyT2 mutations in startle disease. Biological Chemistry, 393 (4). pp. 283-289. 10.1515/bc-2011-232.
Full text not available from this repository.
Startle disease affects newborn children and involves an exaggerated startle response and muscle hypertonia in response to acoustic or tactile stimuli. The primary cause of startle disease is defective inhibitory glycinergic transmission due to mutations in the postsynaptic glycine receptor (GlyR) α1 subunit gene (GLRA1). However, mutations have also been discovered in the genes encoding the GlyR β subunit (GLRB) and the presynaptic glycine transporter GlyT2 (SLC6A5). GlyT2 mutations have also been detected in Belgian Blue cattle and Irish Wolfhounds, where they have significant economic and animal welfare impacts.
|Uncontrolled Keywords:||glycine transporters; GlyR; GlyT2; hyperekplexia; startle disease|
|Departments, units and centres:||Department of Pharmacology > Department of Pharmacology|
|Journal or Publication Title:||Biological Chemistry|
|Deposited By:||Library Staff|
|Deposited On:||04 May 2012 15:02|
|Last Modified:||04 May 2012 15:02|
Item downloaded times since 04 May 2012 15:02.
Repository Staff Only: Item control page
School of Pharmacy Staff Only: Edit a copy to replace this item